The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
Antibody therapies such as convalescent plasma and monoclonal antibodies have emerged as major potential therapeutics for coronavirus disease 2019 (COVID-19). Immunoglobulins differ from conventional antimicrobial agents in that they mediate direct and indirect antimicrobial effects that work in co...
Guardado en:
Autores principales: | Arturo Casadevall, Liise-anne Pirofski, Michael J. Joyner |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8c5b8ee90d8c4f3eb4d30df870e01f9a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework
por: Liise-anne Pirofski, et al.
Publicado: (2020) -
Immune-Mediated Damage Completes the Parabola: <italic toggle="yes">Cryptococcus neoformans</italic> Pathogenesis Can Reflect the Outcome of a Weak or Strong Immune Response
por: Liise-anne Pirofski, et al.
Publicado: (2017) -
Benefits and Costs of Animal Virulence for Microbes
por: Arturo Casadevall, et al.
Publicado: (2019) -
Reduction of <named-content content-type="genus-species">Streptococcus pneumoniae</named-content> Colonization and Dissemination by a Nonopsonic Capsular Polysaccharide Antibody
por: Christopher R. Doyle, et al.
Publicado: (2016) -
Antibodies to <named-content content-type="genus-species">Streptococcus pneumoniae</named-content> Capsular Polysaccharide Enhance Pneumococcal Quorum Sensing
por: Masahide Yano, et al.
Publicado: (2011)